- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04816617
The Effect of Exercise on Preventing Depression in Young People
March 24, 2022 updated by: Kangguang Lin, Guangzhou Psychiatric Hospital
A Multi-center, 12-month,Parallel-group, Randomised Controlled Exercise Trial in Young People With Subthreshold Depression
It is estimated that approximately 30% of child and adolescents manifest subthreshold depression, which can further develop into major depression with as high as 25%-50% within one year.
The main aim of this trial is to investigate the effect of long-term exercise on preventing major depression and depressive symptoms in young people (aged 10-17 years old).
Other aims include the underlying mechanisms of how aerobic exercise works and predictors for treatment response.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This is multi-center, psycho-education randomized controlled trial, consisting of two periods with each of 6 months (i.e supervised and maintenance period).
In the exercise intervention arm, during the first 6 months, participants will be asked to do moderate-intensity aerobic exercise 3-4 times a week, which will be supervised in person by physical educators/professionals.
In the next 6-month maintenance period, participants will be asked to continue doing aerobic exercise at the same intensity and frequency, which will not be supervised in person by educators/professionals, but they will be sent reminders and report adherence weekly.
All of the physical activity will be recorded by accelerometer at scheduled time points (e.g. the first week, 6 week, 3 month, 6 month, 9 month, 12 month).
Psycho-education group will be given 6 sections of general psycho-education onsite and/or virtually dependent on the surroundings with regards to the impact of the COVID-19 pandemic.
The main aim of this trial is to investigate the effect of long-term aerobic exercise on prevention depression in young people with subthreshold depression.
Study Type
Interventional
Enrollment (Anticipated)
370
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Kangguang Lin, MD,PhD
- Phone Number: 86-02081268189
- Email: linkangguang@163.com
Study Locations
-
-
Guangdong
-
Shaoxing, Guangdong, China
- Recruiting
- The first Huaiji middle school
-
Contact:
- Kangguang Lin, MD, Ph.D
- Phone Number: 8613560360144
- Email: klin@gzhmu.edu.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
10 years to 17 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- There are two or more Diagnostic and Statistical Manual of Mental Disorder (DSM)-5 depressive symptoms, including at least one core symptom.
- Any of the core symptoms of subclinical depressive syndrome lasts at least one week, with symptom manifestation ≥50% of the time.
- CES-DC ≥16 points, Altman Self-Rated Mania Scale (ASRM) < 13 points.
- 10~17 years old.
Exclusion Criteria:
- Current or past DSM-5 criteria for major depressive disorder,Bipolar disorder, Schizophrenia.
- With moderate or above suicide risk determined by Columbia-Suicide Severity Rating Scale (C-SSRS) (who will be referred to psychologist and/or psychiatrist for follow-up intervention)
- Musculoskeletal problems such as arthritis, gout, osteoporosis, or back, hip or knee pain that may interfere with exercising
- A history of organic brain disease or brain trauma
- Alcohol, drug or other psychoactive substance abuse or dependence
- Currently enrolled in another exercise study
- Any condition that would make exercise unsafe or unwise
- Taking medication that interferes with heart rate response to exercise such as beta blockers
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Aerobic Exercise
The whole exercise lasts for 12 months, consisted of 6-month supervised exercise and 6-month maintenance period.
It is moderate -intensity exercise (60-80% Maximum heart rate), each time last for 30 mins (plus 10-minutes for warm-up and cool-down), 3-4 times a week, for the first six months, which will be supervised in person by physical educators and/or physical professionals.
In the maintenance period, participants are asked to exercise at the same intensity and frequency, but will not be supervised in person by physical educators/professionals.
They will receive reminder on a weekly basis and their physical activities be recorded by accelerometer.
Types of exercise will be chosen according to individual school's facility and feasibility, including jogging, fast walking, badminton, running, football etc.
|
The whole exercise lasts for 12 months, consisted of 6-month supervised exercise and 6-month maintenance period.
It is moderate -intensity exercise (60-80% Maximum heart rate), each time last for 30 mins (plus 10-minutes for warm-up and cool-down), 3-4 times a week, for the first six months, which will be supervised in person by physical educators and/or physical professionals.
In the maintenance period, participants are asked to exercise at the same intensity and frequency, but will not be supervised in person by physical educators/professionals.
They will receive reminder on a weekly basis and their physical activities be recorded by accelerometer.
Types of exercise will be chosen according to individual school's facility and feasibility, including jogging, fast walking, badminton, running, football etc.
|
Placebo Comparator: Psycho-education
It consists of 6 sections of psycho-education, with topics covering mood regulations and mental well-being.
Approximately 1 section in every two months.
|
It consists of 6 sections of psycho-education, with topics covering mood regulations and mental well-being.
Approximately 1 section in every two months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Onset of Major depressive Disorder (MDD)
Time Frame: month 6 and month 12
|
Kiddie-Sads-Present and Lifetime Version (K-SADS-PL)
|
month 6 and month 12
|
Changes from baseline in CES-DC at month 6
Time Frame: month 6 and month 12
|
Center for Epidemiological Studies Depression Scale for Children (CES-DC) is a self rating scale and has been shown to be effective in groups aged 6-23.
CES-DC is used to measure the depressive severity;its measured time range is within the past week.
In this study, version of 20-items is used.
The higher the score indicates the more severe the depression symptoms, the scale author recommends 15 points as the screening demarcation value.
|
month 6 and month 12
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Cognitive function from baseline
Time Frame: Month 3,6 and month 12
|
Cognitive function is measured by THINC-it tool, a tool for cognitive assessment.
|
Month 3,6 and month 12
|
Levels of inflammatory biomarkers from baseline
Time Frame: Month 3, 6 and month 12
|
inflammatory biomarkers (IL-6, CRP etc) will be analyzed using ELISA
|
Month 3, 6 and month 12
|
Brain structural and functional changes over time
Time Frame: month 3,6, or 12
|
Multimodal 3T MRI will be used
|
month 3,6, or 12
|
Occurrence of Non-suicidal self-injury and suicidal behavior
Time Frame: Month 6 and month 12
|
Month 6 and month 12
|
|
Physical activity level
Time Frame: Month 6, 9 and 12
|
The International Physical Activity Questionnaire - Short Form (IPAQ - SF) will be used to assess physical activity level
|
Month 6, 9 and 12
|
Electroencephalograph (EEG) scalp signal changes over time
Time Frame: Month 3, 6 and 12
|
Brain activity will be measured by the EEG
|
Month 3, 6 and 12
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Kangguang Lin, MD,PhD, The Affiliated Brain Hospital of Guangzhou Medical University
- Principal Investigator: Tifei Yuan, PhD, Shanghai Mental Health Center
- Study Chair: Kwok-Fai So, PhD, Jinan University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 21, 2021
Primary Completion (Anticipated)
May 20, 2023
Study Completion (Anticipated)
December 6, 2023
Study Registration Dates
First Submitted
March 23, 2021
First Submitted That Met QC Criteria
March 23, 2021
First Posted (Actual)
March 25, 2021
Study Record Updates
Last Update Posted (Actual)
April 5, 2022
Last Update Submitted That Met QC Criteria
March 24, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Exercise and MDD prevention
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Exercise
-
Faculdade de Motricidade HumanaCompletedGreen Exercise | Indoor ExercisePortugal
-
Hasan Kalyoncu UniversityNot yet recruiting
-
University of HawaiiKlein Buendel, Inc.CompletedMomZing Exercise Videos Online | Standard Exercise DVDUnited States
-
Istanbul Medipol University HospitalCompletedPulmonary Rehabilitation | Exercise Capacity | Exercise TestTurkey
-
University Hospital MuensterGerman Federal Ministry of Education and ResearchUnknownAerobic Exercise | Anaerobic Exercise | Unchanged ConditionGermany
-
Paracelsus Medical UniversityDepartment of Psychiatry University of BonnRecruitingHealthy | Exercise | Physical Fitness | Exercise TestAustria
-
Nathaniel JenkinsCompletedExercise Training | Physical Exertion | Desire to ExerciseUnited States
-
University of GeorgiaRecruitingBiomarkers | Aerobic Exercise | Acute ExerciseUnited States
-
University of TaipeiCompletedAerobic Exercise | Massage | Anaerobic Exercise
-
University of Alberta, Physical EducationCompletedSedentary Behaviour | Adherence | Traditional Exercise | Lifestyle ExerciseCanada
Clinical Trials on Aerobic exercise intervention
-
VA Office of Research and DevelopmentCompletedHeart FailureUnited States
-
University of AarhusNot yet recruiting
-
Turku University HospitalUniversity of Turku; University of Helsinki; Academy of Finland; European Foundation... and other collaboratorsUnknownType 2 Diabetes Mellitus | Healthy VolunteersFinland
-
University of South CarolinaCompletedPhysical Activity | Sedentary Lifestyle | Metabolism Disorder, GlucoseUnited States
-
University of TorontoTerminated
-
Radboud University Medical CenterUMC Utrecht; Catharina Ziekenhuis Eindhoven; Amsterdam UMC, location VUmc; Academisch... and other collaboratorsRecruitingColorectal Cancer | Chemotherapeutic Toxicity | Lifestyle | SurvivorshipNetherlands
-
University of ValenciaRecruiting
-
VA Office of Research and DevelopmentCompletedExercise | AgingUnited States
-
University of AlbertaCompleted
-
The University of Hong KongQueen Mary Hospital, Hong KongRecruitingTai-Chi and Aerobic Exercise to Improve Emotional Symptom Cluster in Late-stage Lung Cancer PatientsAdvanced Lung Non-Small Cell CarcinomaHong Kong